about
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...
Read More
23.54
0.64
(2.79%)
293.0K
XNAS Volume
XNAS 10 Mar, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for DBV Tech (ADR) took place on 10 Mar 2026, for the purpose of Citizens Life Sciences Conference
See details
Not Eligible
Expensive Valuation
Technically Bullish
DBV Tech (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..